yungjin pharmaceutical company ltd
D-Pharm Gets South Korean Approval For Phase III Study Of Neuro Drug
D-Pharm Ltd. announced this week that the KFDA has approved the IND application for the Phase III MACSI study of DP-b99 in Korea.
D-Pharm Ltd. announced this week that the KFDA has approved the IND application for the Phase III MACSI study of DP-b99 in Korea.
